Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Livingstone E, Zimmer L, Hassel JC, Fluck M, et al. Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial. Lancet 2022 Sep 9. pii: S0140-6736(22)01654.
PMID: 36099927

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016